Galectin-3 Predicts Response to Statin Therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)

Study Questions:

Can plasma galectin-3 (a mediator of fibrogenesis) predict patients with chronic heart failure (HF) for whom statins are effective?